Faeth Therapeutics
2 known investors
Faeth Therapeutics develops PIKTOR, an oral multi-node inhibitor targeting the PI3K/AKT/mTOR pathway for cancer treatment, currently in clinical trials for endometrial and breast cancer.
BiotechDigital HealthMedical Devices